Home » Anchen Pharmaceuticals Receives FDA Approval for Leukemia Drug
Anchen Pharmaceuticals Receives FDA Approval for Leukemia Drug
Anchen Pharmaceuticals received final approval from the FDA for its abbreviated new drug application for tretinoin capsules, 10 mg.
Equities
Equities
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May